Literature DB >> 1122689

Diphenylhydantoin elimination kinetics in overdosed children.

L K Garrettson, W J Jusko.   

Abstract

Diphenylhydantoin (DPH) elimination was studied in 4 overdosed children who presented with serum concentrations ranging from 44 to 76 mg/l. Serum was assayed for DPH and urine was assayed for both DPH and 5-(p-hydroxyphenyl)-5-phenylhydantoin (HPPH). The serum and urine data were subjected to simultaneous computer nonlinear regression analysis using a one-compartment pharmacokinetic model, which accounts for much of the known disposition kinetics of DPH. Computed values for the apparent in vivo Michaelis-Menten constants, K-M and V max, were compared with values derived from data in the literature for normal adult subjects. A trend toward relatively lower K-M and higher V max/K-M values was seen in children. Patients with higher V max values had greater urinary excretion rates of HPPH which, at high serum levels of DPH, were relatively constant except for an apparent diurnal rhythm. The time of onset of DPH toxicity in the children was related to the magnitude by which the rate of DPH administration exceeded the V max values.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1122689     DOI: 10.1002/cpt1975174481

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  Circadian variation in urinary excretion of ciprofloxacin after a single-dose oral administration at 1000 and 2200 hours in human subjects.

Authors:  V V Rao; D Rambhau; B R Rao; P Srinivasu
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination.

Authors:  P Veng-Pedersen; J A Widness; J Wang; R L Schmidt
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

3.  Nonlinear assessment of phenytoin bioavailability.

Authors:  W J Jusko; J R Koup; G Alván
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

4.  Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Authors:  G Lam; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

Review 5.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 6.  Clinical features and management of poisoning due to phenytoin.

Authors:  J R Larsen; L S Larsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 7.  Individual differences in the disposition of drugs metabolised in the body.

Authors:  G Alvan
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Phenytoin elimination kinetics in two children with drug intoxication.

Authors:  K Abe; M Okano; H Sasaki
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

10.  Nomographic estimation of time to reach steady-state serum concentration during phenytoin therapy.

Authors:  S Vozeh; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.